We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Drugmaker Neuromed Pharmaceuticals Ltd. said Tuesday it has licensed the U.S.
rights to develop and market a once-a-day pain reliever from a unit of Johnson
& Johnson. ABCmoney